Bringing Alzheimer’s drug within reach with AVEVA™ PI System™

Biogen wanted to manufacture enough Aducanumab to treat one million Alzheimer’s patients worldwide—but that required increasing production, improving yield, and reducing costs. The company used AVEVA PI System to enable real-time visibility and contextualized insights on the plant floor. With real-time review by exception, teams can now make adjustments before the batch moves on to the next step, allowing the company to reduce costs, increase yield, and expand production efforts. 

“Our goal with AVEVA PI System is to turn it into a central point of information driving some of our really key, data-rich applications and work processes.”

Tim Alosi, Head of Global Digital Analytics Team, Biogen

Contact AVEVA
Live Chat
Schedule Demo